Revvity Slashes Outlook As China Policy Deals Diagnostics Blow

Revvity Slashes Outlook As China Policy Deals Diagnostics Blow

Upworthy

Published

In This Article: Revvity Inc. (NYSE:RVTY) stock is trading lower on Monday following the life science tools maker’s second-quarter 2025 earnings report, which also included a trimmed profit forecast for 2025. The Massachusetts-based company announced second-quarter sales of $720.28 million, an…

Full Article